← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 14, 2018Last known activity
Feb 10, 2022
Acquired by Centessa on Feb 17, 2021
Timeline
2010s
- Jun 1, 2015
Palladio Biosciences— Founded
2020s
- Feb 17, 2021
Centessa— Acquired By
Drugs by trial phase (1 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT05208866Lead sponsorPhase 3Feb 10, 2022
- NCT04064346Lead sponsorPhase 3Mar 31, 2020
- NCT04152837Lead sponsorPhase 3Feb 29, 2020
- NCT03717181Lead sponsorPhase 2Jan 1, 2019
- NCT03487913Lead sponsorPhase 2Sep 14, 2018
Details
- Founded
- Newtown, PA, US Jun 1, 2015
- Last known activity
- Feb 10, 2022